Evelo Biosciences Ownership 2024 | Who Owns Evelo Biosciences Now?

OverviewFinancials Chart

Institutional Ownership

0.40%

Insider Ownership

0.14%

Retail Ownership

99.46%

Institutional Holders

1.00

Evelo Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MAYO CLINIC	-	-	-	-22,577	-100.00%	-	Dec 31, 2023

Evelo Biosciences's largest institutional shareholder is MAYO CLINIC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MAYO CLINIC	-	-	-	-22,577	-100.00%	-	Dec 31, 2023

The largest Evelo Biosciences shareholder by % of total assets is MAYO CLINIC. The company owns 0.00 shares of Evelo Biosciences (EVLO), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MAYO CLINIC	-	-	-	-22,577	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, Evelo Biosciences's largest institutional buyer is MAYO CLINIC. The company purchased -22.58K stocks of EVLO, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MAYO CLINIC	-	-	-	-22,577	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, Evelo Biosciences's biggest institutional seller is MAYO CLINIC. The company sold -22.58K shares of EVLO, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MAYO CLINIC	-	-	-	-22,577	-100.00%	-	Dec 31, 2023

Evelo Biosciences's largest sold out institutional shareholder by shares sold is MAYO CLINIC, sold -22.58K shares, valued at -, as of undefined.

Evelo Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY MT VERNON STREET TRUST	0.14%	3,908,340	-	-	Feb 29, 2024
BRIDGEWAY FUNDS INC	0.04%	105,300	-	-	Mar 28, 2024
VANGUARD VALLEY FORGE FUNDS	0.04%	22,014	-	-	Mar 31, 2024
FIDELITY CAPITAL TRUST	0.03%	379,400	-	-	Jan 31, 2024
Federated Hermes MDT Series	0.03%	70,217	-	-	Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND	0.02%	466,900	-	-	Mar 31, 2024
FIDELITY SELECT PORTFOLIOS	0.02%	1,098,999	-	-	Feb 29, 2024
FIDELITY COMMONWEALTH TRUST	0.02%	51,109	-	-	Feb 29, 2024
ETFis Series Trust I	0.01%	21,013	-	-	Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.01%	4,653	-	-	Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC	0.01%	47,428	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.01%	3,062,966	-	-	Mar 31, 2024
Humankind Benefit Corp	0.00%	111	-	-	Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 1	0.00%	887	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	492,530	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	54,959	-	-	Mar 31, 2024
FIDELITY ADVISOR SERIES I	0.00%	329,200	-	-	Feb 29, 2024
FIDELITY CAPITAL TRUST	0.00%	18,970	-	-	Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND III	0.00%	12,700	-	-	Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND	0.00%	21,645	-	-	Mar 31, 2024
VICTORY PORTFOLIOS	0.00%	27,769	-	-	Mar 31, 2024
Calvert Variable Products, Inc.	0.00%	2,381	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	348,664	-	-	Mar 31, 2024
AdvisorShares Trust	0.00%	3,207	-	-	Mar 28, 2024
SCHWAB CAPITAL TRUST	0.00%	31,345	-	-	Feb 29, 2024
TIAA-CREF LIFE FUNDS	0.00%	2,030	-	-	Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC	0.00%	12,008	-	-	Mar 31, 2024
VANGUARD WORLD FUND	0.00%	85,629	-	-	Feb 29, 2024
SunAmerica Specialty Series	0.00%	165	-	-	Apr 30, 2021
GPS Funds I	0.00%	1,521	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	51,357	-	-	Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	2,640	-	-	Mar 31, 2024
FIDELITY SELECT PORTFOLIOS	0.00%	13,449	-	-	Feb 29, 2024
Global X Funds	0.00%	8,579	-	-	Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC	0.00%	897	-	-	Mar 31, 2024
SCHWAB STRATEGIC TRUST	0.00%	105,799	-	-	Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	6,535	-	-	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	2,747	-	-	Mar 31, 2024
FIDELITY ADVISOR SERIES I	0.00%	16,460	-	-	Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND III	0.00%	635	-	-	Mar 31, 2024
RBB FUND, INC.	0.00%	6,908	-	-	Feb 29, 2024
HC CAPITAL TRUST	0.00%	2,314	-	-	Mar 31, 2024
RYDEX SERIES FUNDS	0.00%	289	-	-	Dec 31, 2023
NORTHERN FUNDS	0.00%	9,303	-	-	Mar 28, 2024
ProFunds	0.00%	649	-	-	Mar 31, 2024
FIDELITY SALEM STREET TRUST	0.00%	212,429	-	-	Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	103,556	-	-	Feb 29, 2024
T. Rowe Price Index Trust, Inc.	0.00%	1,052	-	-	Feb 29, 2024
RYDEX DYNAMIC FUNDS	0.00%	161	-	-	Dec 31, 2023
VALIC Co I	0.00%	11,257	-	-	Feb 29, 2024
Guardian Variable Products Trust	0.00%	620	-	-	Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	4,051	-	-	Mar 31, 2024
Guggenheim Active Allocation Fund	0.00%	181	-	-	Feb 29, 2024
iSHARES TRUST	0.00%	482,382	-	-	Mar 31, 2024
PROSHARES TRUST	0.00%	7,320	-	-	Feb 29, 2024
FIDELITY HASTINGS STREET TRUST	0.00%	187,600	-	-	Mar 31, 2024
MASTER INVESTMENT PORTFOLIO	0.00%	2,385	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	6,016	-	-	Jan 31, 2024
RYDEX VARIABLE TRUST	0.00%	29	-	-	Dec 31, 2023
VANGUARD WELLINGTON FUND	0.00%	9,937	-	-	Feb 29, 2024
PENN SERIES FUNDS INC	0.00%	700	-	-	Mar 28, 2024
TIAA-CREF FUNDS	0.00%	70,514	-	-	Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND	0.00%	22,743	-	-	Mar 31, 2024
FLEXSHARES TRUST	0.00%	1,504	-	-	Jan 31, 2024
SEI INSTITUTIONAL MANAGED TRUST	0.00%	55,533	-	-	Dec 31, 2023
PACE SELECT ADVISORS TRUST	0.00%	4,786	-	-	Jan 31, 2024
Brighthouse Funds Trust II	0.00%	12,153	-	-	Mar 31, 2024
ALLSPRING MASTER TRUST	0.00%	841	-	-	Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	1,296	-	-	Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	26,000	-	-	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	600	-	-	Mar 31, 2023
ETF Series Solutions	0.00%	203	-	-	Jan 31, 2024
SUNAMERICA SERIES TRUST	0.00%	3,349	-	-	Mar 31, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	2,084	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	2,455	-	-	Jan 31, 2024
PROSHARES TRUST	0.00%	1,201	-	-	Feb 29, 2024
EQ ADVISORS TRUST	0.00%	5,374	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,014	-	-	Jan 31, 2024
iSHARES TRUST	0.00%	64,989	-	-	Mar 31, 2024
PACIFIC SELECT FUND	0.00%	10,459	-	-	Mar 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	347	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	2,447	-	-	Jan 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	2,392	-	-	Dec 31, 2023
GOLDMAN SACHS TRUST	0.00%	5,950	-	-	Mar 31, 2024
FIDELITY HASTINGS STREET TRUST	0.00%	9,380	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	2,584	-	-	Mar 31, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	310	-	-	Jan 31, 2024
AMERICAN CENTURY ETF TRUST	0.00%	99	-	-	Feb 29, 2024
PRINCIPAL FUNDS, INC.	0.00%	5,243	-	-	Feb 29, 2024
Bridge Builder Trust	0.00%	3,643	-	-	Mar 31, 2024
BlackRock Variable Series Funds, Inc.	0.00%	3,622	-	-	Mar 31, 2024
PACIFIC SELECT FUND	0.00%	2,066	-	-	Mar 31, 2024
BLACKROCK FUNDS	0.00%	3,117	-	-	Mar 28, 2024
Advisors' Inner Circle Fund III	0.00%	35	-	-	Jan 31, 2024
John Hancock Funds II	0.00%	3,221	-	-	Feb 29, 2024
Meeder Funds	0.00%	1	-	-	Mar 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST	0.00%	3,300	-	-	Feb 29, 2024

Evelo Biosciences's largest mutual fund holder by % of total assets is "FIDELITY MT VERNON STREET TRUST", owning 3.91M shares, compromising 0.14% of its total assets.

Evelo Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 23	1	-
30 Jun, 23	1	-97.30%
31 Mar, 23	37	-11.90%
31 Dec, 22	42	7.69%
30 Sep, 22	39	-11.36%
30 Jun, 22	44	-34.33%
31 Mar, 22	67	-4.29%
31 Dec, 21	70	-11.39%
30 Sep, 21	79	14.49%
30 Jun, 21	69	9.52%
31 Mar, 21	63	28.57%
31 Dec, 20	49	4.26%
30 Sep, 20	47	2.17%
30 Jun, 20	46	15.00%
31 Mar, 20	40	-4.76%
31 Dec, 19	42	-
30 Sep, 19	42	10.53%
30 Jun, 19	38	-7.32%
31 Mar, 19	41	2.50%
31 Dec, 18	40	8.11%
30 Sep, 18	37	-9.76%
30 Jun, 18	41	-

As of 30 Sep 23, 1 institutions are holding Evelo Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 23	22,577	-
30 Jun, 23	22,577	-99.97%
31 Mar, 23	84,899,862	-0.77%
31 Dec, 22	85,562,817	1.34%
30 Sep, 22	84,434,362	1.19%
30 Jun, 22	83,441,450	75.38%
31 Mar, 22	47,578,027	-0.46%
31 Dec, 21	47,798,182	1.55%
30 Sep, 21	47,066,391	0.20%
30 Jun, 21	46,970,964	-1.07%
31 Mar, 21	47,477,488	12.90%
31 Dec, 20	42,051,001	4.82%
30 Sep, 20	40,116,453	-1.60%
30 Jun, 20	40,770,751	42.47%
31 Mar, 20	28,616,999	-1.20%
31 Dec, 19	28,965,738	0.77%
30 Sep, 19	28,743,783	0.20%
30 Jun, 19	28,686,727	0.37%
31 Mar, 19	28,582,372	1.48%
31 Dec, 18	28,165,859	3.81%
30 Sep, 18	27,131,973	1.94%
30 Jun, 18	26,616,560	-

Evelo Biosciences (EVLO) has 22.58K shares outstanding as of 30 Sep 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 23	0.40%	97450.98%
30 Jun, 23	0.02%	0.00%
31 Mar, 23	76.55%	0.79%
31 Dec, 22	98.16%	1.61%
30 Sep, 22	78.14%	0.64%
30 Jun, 22	110.20%	1.40%
31 Mar, 22	88.73%	1.09%
31 Dec, 21	90.34%	1.16%
30 Sep, 21	88.09%	1.14%
30 Jun, 21	87.99%	1.03%
31 Mar, 21	92.47%	0.82%
31 Dec, 20	106.51%	1.41%
30 Sep, 20	86.89%	0.56%
30 Jun, 20	124.93%	1.59%
31 Mar, 20	88.73%	1.09%
31 Dec, 19	90.43%	1.12%
30 Sep, 19	89.65%	1.12%
30 Jun, 19	89.53%	1.12%
31 Mar, 19	89.53%	0.54%
31 Dec, 18	128.78%	1.76%
30 Sep, 18	85.48%	0.46%
30 Jun, 18	135.61%	-

As of 30 Sep 23, Evelo Biosciences is held by 0.40% institutional shareholders, representing a 97450.98% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 23	-	-
30 Jun, 23	-	-100.00%
31 Mar, 23	12	-50.00%
31 Dec, 22	24	60.00%
30 Sep, 22	15	-11.76%
30 Jun, 22	17	-37.04%
31 Mar, 22	27	-27.03%
31 Dec, 21	37	-9.76%
30 Sep, 21	41	-
30 Jun, 21	41	-10.87%
31 Mar, 21	46	39.39%
31 Dec, 20	33	26.92%
30 Sep, 20	26	-16.13%
30 Jun, 20	31	106.67%
31 Mar, 20	15	-16.67%
31 Dec, 19	18	-10.00%
30 Sep, 19	20	-
30 Jun, 19	20	-9.09%
31 Mar, 19	22	-18.52%
31 Dec, 18	27	28.57%
30 Sep, 18	21	-48.78%
30 Jun, 18	41	-

- institutional shareholders have increased their position in EVLO stock as of 30 Sep 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 23	-	-100.00%
30 Jun, 23	1	-90.00%
31 Mar, 23	10	42.86%
31 Dec, 22	7	-46.15%
30 Sep, 22	13	-35.00%
30 Jun, 22	20	-20.00%
31 Mar, 22	25	78.57%
31 Dec, 21	14	-
30 Sep, 21	14	-12.50%
30 Jun, 21	16	33.33%
31 Mar, 21	12	50.00%
31 Dec, 20	8	-27.27%
30 Sep, 20	11	37.50%
30 Jun, 20	8	-46.67%
31 Mar, 20	15	25.00%
31 Dec, 19	12	20.00%
30 Sep, 19	10	25.00%
30 Jun, 19	8	-27.27%
31 Mar, 19	11	83.33%
31 Dec, 18	6	-14.29%
30 Sep, 18	7	-
30 Jun, 18	-	-

- institutional shareholders have reduced their position in EVLO stock as of 30 Sep 23 compared to 1 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 23	1	-	22,577	-	0.40%	97450.98%	-	-	-	-100.00%
30 Jun, 23	1	-97.30%	22,577	-99.97%	0.02%	0.00%	-	-100.00%	1	-90.00%
31 Mar, 23	37	-11.90%	84,899,862	-0.77%	76.55%	0.79%	12	-50.00%	10	42.86%
31 Dec, 22	42	7.69%	85,562,817	1.34%	98.16%	1.61%	24	60.00%	7	-46.15%
30 Sep, 22	39	-11.36%	84,434,362	1.19%	78.14%	0.64%	15	-11.76%	13	-35.00%
30 Jun, 22	44	-34.33%	83,441,450	75.38%	110.20%	1.40%	17	-37.04%	20	-20.00%
31 Mar, 22	67	-4.29%	47,578,027	-0.46%	88.73%	1.09%	27	-27.03%	25	78.57%
31 Dec, 21	70	-11.39%	47,798,182	1.55%	90.34%	1.16%	37	-9.76%	14	-
30 Sep, 21	79	14.49%	47,066,391	0.20%	88.09%	1.14%	41	-	14	-12.50%
30 Jun, 21	69	9.52%	46,970,964	-1.07%	87.99%	1.03%	41	-10.87%	16	33.33%
31 Mar, 21	63	28.57%	47,477,488	12.90%	92.47%	0.82%	46	39.39%	12	50.00%
31 Dec, 20	49	4.26%	42,051,001	4.82%	106.51%	1.41%	33	26.92%	8	-27.27%
30 Sep, 20	47	2.17%	40,116,453	-1.60%	86.89%	0.56%	26	-16.13%	11	37.50%
30 Jun, 20	46	15.00%	40,770,751	42.47%	124.93%	1.59%	31	106.67%	8	-46.67%
31 Mar, 20	40	-4.76%	28,616,999	-1.20%	88.73%	1.09%	15	-16.67%	15	25.00%
31 Dec, 19	42	-	28,965,738	0.77%	90.43%	1.12%	18	-10.00%	12	20.00%
30 Sep, 19	42	10.53%	28,743,783	0.20%	89.65%	1.12%	20	-	10	25.00%
30 Jun, 19	38	-7.32%	28,686,727	0.37%	89.53%	1.12%	20	-9.09%	8	-27.27%
31 Mar, 19	41	2.50%	28,582,372	1.48%	89.53%	0.54%	22	-18.52%	11	83.33%
31 Dec, 18	40	8.11%	28,165,859	3.81%	128.78%	1.76%	27	28.57%	6	-14.29%
30 Sep, 18	37	-9.76%	27,131,973	1.94%	85.48%	0.46%	21	-48.78%	7	-
30 Jun, 18	41	-	26,616,560	-	135.61%	-	41	-	-	-

Evelo Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 08, 2023	Bodmer Mark	officer	CSO, President of R&D	S-Sale	Sell	3,163	$0.33	$1.04K	25,732
Nov 08, 2023	McHale Duncan	officer	Chief Medical Officer	S-Sale	Sell	3,103	$0.33	$1.02K	16,984
Nov 08, 2023	GILL SIMBA	director, officer	President & CEO	S-Sale	Sell	172	$0.33	$56.76	17,758
Nov 08, 2023	Thorell Marella	officer	Chief Financial Officer	S-Sale	Sell	1,811	$0.33	$597.63	22,259
Nov 03, 2023	Bodmer Mark	officer	CSO, President of R&D	S-Sale	Sell	6,854	$0.33	$2.26K	22,270
Nov 03, 2023	McHale Duncan	officer	Chief Medical Officer	S-Sale	Sell	6,854	$0.33	$2.26K	13,587

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 08, 2023	Bodmer Mark	officer	CSO, President of R&D	S-Sale	Sell	3,163	$0.33	$1.04K	25,732
Nov 08, 2023	Bodmer Mark	officer	CSO, President of R&D	M-Exempt	Sell	6,625	-	-	6,625
Nov 08, 2023	McHale Duncan	officer	Chief Medical Officer	S-Sale	Sell	3,103	$0.33	$1.02K	16,984
Nov 08, 2023	McHale Duncan	officer	Chief Medical Officer	M-Exempt	Sell	6,500	-	-	6,500
Nov 08, 2023	GILL SIMBA	director, officer	President & CEO	S-Sale	Sell	172	$0.33	$56.76	17,758
Nov 08, 2023	GILL SIMBA	director, officer	President & CEO	M-Exempt	Sell	1,172	-	-	15,236
Nov 08, 2023	Thorell Marella	officer	Chief Financial Officer	S-Sale	Sell	1,811	$0.33	$597.63	22,259
Nov 08, 2023	Thorell Marella	officer	Chief Financial Officer	M-Exempt	Sell	6,500	-	-	6,500
Nov 03, 2023	Bodmer Mark	officer	CSO, President of R&D	M-Exempt	Sell	12,500	-	-	25,000
Nov 03, 2023	Bodmer Mark	officer	CSO, President of R&D	S-Sale	Sell	6,854	$0.33	$2.26K	22,270
Nov 03, 2023	McHale Duncan	officer	Chief Medical Officer	M-Exempt	Sell	12,500	-	-	25,000
Nov 03, 2023	McHale Duncan	officer	Chief Medical Officer	S-Sale	Sell	6,854	$0.33	$2.26K	13,587
Nov 03, 2023	Thorell Marella	officer	Chief Financial Officer	M-Exempt	Sell	12,500	-	-	25,000

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 08, 2023	Bodmer Mark	officer	CSO, President of R&D	M-Exempt	Buy	6,625	-	-	28,895
Nov 08, 2023	Bodmer Mark	officer	CSO, President of R&D	S-Sale	Sell	3,163	$0.33	$1.04K	25,732
Nov 08, 2023	Bodmer Mark	officer	CSO, President of R&D	M-Exempt	Sell	6,625	-	-	6,625
Nov 08, 2023	McHale Duncan	officer	Chief Medical Officer	M-Exempt	Buy	6,500	-	-	20,087
Nov 08, 2023	McHale Duncan	officer	Chief Medical Officer	S-Sale	Sell	3,103	$0.33	$1.02K	16,984
Nov 08, 2023	McHale Duncan	officer	Chief Medical Officer	M-Exempt	Sell	6,500	-	-	6,500
Nov 08, 2023	GILL SIMBA	director, officer	President & CEO	M-Exempt	Buy	1,172	-	-	17,930
Nov 08, 2023	GILL SIMBA	director, officer	President & CEO	S-Sale	Sell	172	$0.33	$56.76	17,758
Nov 08, 2023	GILL SIMBA	director, officer	President & CEO	M-Exempt	Sell	1,172	-	-	15,236
Nov 08, 2023	Thorell Marella	officer	Chief Financial Officer	M-Exempt	Buy	6,500	-	-	24,070
Nov 08, 2023	Thorell Marella	officer	Chief Financial Officer	S-Sale	Sell	1,811	$0.33	$597.63	22,259
Nov 08, 2023	Thorell Marella	officer	Chief Financial Officer	M-Exempt	Sell	6,500	-	-	6,500
Nov 03, 2023	Bodmer Mark	officer	CSO, President of R&D	M-Exempt	Buy	12,500	-	-	29,124
Nov 03, 2023	Bodmer Mark	officer	CSO, President of R&D	M-Exempt	Sell	12,500	-	-	25,000
Nov 03, 2023	Bodmer Mark	officer	CSO, President of R&D	S-Sale	Sell	6,854	$0.33	$2.26K	22,270
Nov 03, 2023	McHale Duncan	officer	Chief Medical Officer	M-Exempt	Sell	12,500	-	-	25,000
Nov 03, 2023	McHale Duncan	officer	Chief Medical Officer	M-Exempt	Buy	12,500	-	-	20,441
Nov 03, 2023	McHale Duncan	officer	Chief Medical Officer	S-Sale	Sell	6,854	$0.33	$2.26K	13,587
Nov 03, 2023	Thorell Marella	officer	Chief Financial Officer	M-Exempt	Sell	12,500	-	-	25,000
Nov 03, 2023	Thorell Marella	officer	Chief Financial Officer	M-Exempt	Buy	12,500	-	-	21,569

The last insider sell of Evelo Biosciences's stock was made by Bodmer Mark on Nov 08 2023, selling 3,163 shares at $0.33 per share (valued at $1.04K).

Evelo Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	7	14	50.00%
Q3 2023	14	11	127.27%
Q2 2023	15	9	166.67%
Q1 2023	7	2	350.00%
Q3 2022	4	-	-
Q2 2022	13	4	325.00%
Q1 2022	15	4	375.00%
Q4 2021	8	8	100.00%
Q3 2021	3	3	100.00%
Q2 2021	14	1	1400.00%
Q1 2021	14	-	-
Q4 2020	9	1	900.00%
Q3 2020	7	-	-
Q2 2020	10	-	-
Q1 2020	6	3	200.00%
Q4 2019	1	-	-
Q3 2019	1	-	-
Q2 2019	7	-	-
Q1 2019	3	-	-
Q4 2018	1	-	-

7 total buy trades, and 14 total sell trades (buy/sell ratio of 0.50%) were made by Evelo Biosciences's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	-	7	-
Q3 2023	3	5	60.00%
Q2 2023	-	5	-
Q1 2023	-	1	-
Q3 2022	-	-	-
Q2 2022	4	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	4	-	-
Q4 2020	7	1	700.00%
Q3 2020	6	-	-
Q2 2020	4	-	-
Q1 2020	-	-	-
Q4 2019	-	-	-
Q3 2019	-	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-
Q4 2018	-	-	-

As of Q4 2023, Insider owners conducted 0 open market buy trades and 7 open market sell trades of Evelo Biosciences's stocks.

Evelo Biosciences Peer Ownership

Ticker	Company
MGTA	Dianthus Therapeutics, Inc.
NUVB	Nuvation Bio Inc.
ENSC	Ensysce Biosciences, Inc.
NEXI	NexImmune, Inc.
EWTX	Edgewise Therapeutics, Inc.
ABVC	ABVC BioPharma, Inc.
ERAS	Erasca, Inc.
CTMX	CytomX Therapeutics, Inc.
GBIO	Generation Bio Co.
SRZN	Surrozen, Inc.
APTX	Aptinyx Inc.
DRMA	Dermata Therapeutics, Inc.
KRON	Kronos Bio, Inc.
CCCC	C4 Therapeutics, Inc.
ASMB	Assembly Biosciences, Inc.
TPST	Tempest Therapeutics, Inc.
PCSA	Processa Pharmaceuticals, Inc.
WINT	Windtree Therapeutics, Inc.
NLTX	Neurogene Inc.
BXRX	Baudax Bio, Inc.
TIL	Instil Bio, Inc.
ALRN	Aileron Therapeutics, Inc.

EVLO Ownership FAQ

Who Owns Evelo Biosciences?

Evelo Biosciences is owned by institutional shareholders (0.40%), insiders (0.14%), and public (99.46%). The largest institutional shareholder of Evelo Biosciences is MAYO CLINIC (0% of total shares) and the top mutual fund owner is FIDELITY MT VERNON STREET TRUST (0.14% of total shares).

Who are the major institutional shareholders of Evelo Biosciences?

Evelo Biosciences's major institutional shareholders are MAYO CLINIC. The top five shareholders own together 0% of the company's share outstanding.

How many Evelo Biosciences shareholders are there?

As of Sep 2023, there are 1 institutional shareholders of Evelo Biosciences.

What percentage of Evelo Biosciences is owned by MAYO CLINIC?

MAYO CLINIC owns 0 shares of Evelo Biosciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).